To see all protocols that comply with the WHO Essential Medicine List 

Welcome to eviQ

A free resource of evidence-based, consensus driven cancer treatment protocols and information for use at the point of care. eviQ is developed for the Australian context and supports health professionals in the delivery of cancer treatments.

Find out more

 

Latest news

View all news

COVID-19 resources are available for the cancer care community. This includes information for patients and carers and vaccination information.

2021 has been another busy and challenging year. We're proud to share our achievements with you. Thanks for your engagement this year and seasons greetings from the eviQ team!

With the change in biosimilar brand of bevacizumab available on the PBS from 1 June 2021, eviQ is collecting information on how bevacizumab is being administered in clinical practice with the view to inform the update of eviQ protocols in the future. Completion of this survey is voluntary and anonymous and should take approximately 5 minutes. This survey has been extended to close on Monday 7 February 2022.

Test your knowledge with an interactive mini-quiz via the eviQ Education app. Click through to access the QR code and download the app.